SCHEMBL19987628

SCHEMBL19987628

C/N=C/[C@H]1C[C@@H](C)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22546454 0.77 CHRM2 (0.30) —
SCHEMBL18526310 0.76 — —
SCHEMBL14649310 0.76 — —
SCHEMBL7147700 0.71 — —
SCHEMBL4959119 0.71 — —
SCHEMBL25111573 0.71 — —
SCHEMBL4956679 0.71 — —
SCHEMBL7133444 0.71 — —
SCHEMBL13980015 0.71 — —
SCHEMBL4423704 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3360877-B1 1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS WOCKHARDT LTD (IN) 2021-02-17 — — EP disclosed
US-20200071328-A1 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS WOCKHARDT LIMITED (IN) 2020-03-05 — — US disclosed
EP-2961751-B1 1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS WOCKHARDT LTD (IN) 2018-03-21 — — EP disclosed
Send feedback